Day: May 12, 2025

Bright Mountain Media, Inc Announces First Quarter 2025 Financial Results

Written by Customer Service on May 12, 2025. Posted in Public Companies.

First quarter revenue increased 14% to $14.2 million compared to the first quarter of 2024. First quarter gross margin increased 36% to $4.3 million compared to the first quarter of 2024.Boca Raton, FL, May 12, 2025 (GLOBE NEWSWIRE) — Bright Mountain Media, Inc. (OTCQB: BMTM) (“Bright Mountain” or the “Company”), a global holding company with current investments in digital publishing, advertising technology, consumer insights, creative services, and media services, today announced its financial results for the first quarter ended March 31, 2025. Matt Drinkwater, the CEO of Bright Mountain Media, announced continued financial momentum in the first quarter of the year, highlighting solid gains across key performance metrics. “We are very pleased with our strong and steady financial performance”, said Drinkwater. “In...

Matthews International Announces Acquisition of the Dodge Company

Written by Customer Service on May 12, 2025. Posted in Mergers And Acquisitions.

PITTSBURGH, May 12, 2025 (GLOBE NEWSWIRE) — Matthews Memorialization, a division of Matthews International Corporation (NASDAQ GSM: MATW) (“Matthews”), today announced it has acquired The Dodge Company (“Dodge”) for $57 Million. Dodge is a leading supplier of embalming chemicals and supplies in North America and sells a variety of other related products to Funeral Homes. Matthews Memorialization is a leading supplier to Funeral Homes and Cemeteries in North America, selling a broad range of products including caskets, bronze and granite memorials, and cremation equipment. The acquisition advances Matthews’ strategy of providing a comprehensive product offering to its death care industry customers. “We are excited to welcome Dodge and its employees to the Matthews Memorialization family,” said Steve Gackenbach, Matthews Memorialization...

Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition

Written by Customer Service on May 12, 2025. Posted in Mergers And Acquisitions.

Received overwhelming shareholder approval with 99.9% of votes cast in favor Simplified structure benefits shareholders through strengthened shareholder alignment, enhanced governance, significant cash savings and increased economic return on investments Significant annual cash savings of greater than $100 million in 2026 growing to over $175 million in 2030, with cumulative savings of more than $1.6 billion over ten years Royalty Pharma’s diversified royalty portfolio to be combined with intellectual capital and investment platform of the Manager to advance shareholder value creationNEW YORK, May 12, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that shareholders overwhelmingly approved its previously announced external manager acquisition, with 99.9% voting in favor at Royalty Pharma’s 2025 Annual...

Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update

Written by Customer Service on May 12, 2025. Posted in Earnings Releases And Operating Results.

– Strategic transformation to innovative oncology completed in Q2 2025 – – Positive CHS-114 (anti-CCR8 antibody) Phase 1b dose expansion study data in patients with head and neck cancer presented at 2025 AACR Annual Meeting – – Additional CHS-114 Phase 1b studies in 2L gastric cancer and 2L HNSCC ongoing – – Enrollment ongoing in the Phase 2 randomized trial of casdozokitug/toripalimab/bevacizumab in 1L HCC, with first data readout expected in 1H 2026 – – LOQTORZI net revenue was $7.3 million and UDENYCA net revenue, now reflected in discontinued operations, was $31.5 million in Q1 2025 – – Conference call today at 5:00 p.m. Eastern Time – REDWOOD CITY, Calif., May 12, 2025 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus or the Company, Nasdaq: CHRS), today reported financial results for the quarter ended March 31, 2025...

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

Written by Customer Service on May 12, 2025. Posted in Earnings Releases And Operating Results.

Full data from Group 1 in the Phase 2 REGEN-007 study expected in Q2 2025 FDA previously confirmed in a Q4 2024 Type B meeting that the accelerated approval pathway is available for rilparencel; additional details on the accelerated pathway are expected in mid-2025 after our planned Type B meeting with the FDA Ended the first quarter with $328.5 million in cash and cash equivalents and marketable securities, supporting operations into mid-2027WINSTON-SALEM, N.C., May 12, 2025 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today reported financial results and business highlights for the first quarter ended March 31, 2025. “The next two quarters are important for ProKidney as we approach...

Global Ship Lease Declares Quarterly Dividend per Common Share for First Quarter of 2025

Written by Customer Service on May 12, 2025. Posted in Dividend Reports And Estimates.

ATHENS, Greece, May 12, 2025 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today that the Company’s Board of Directors has declared a dividend of $0.525 per Class A common share for the first quarter of 2025, to be paid on June 3, 2025 to shareholders of record as of May 23, 2025. About Global Ship Lease Global Ship Lease is a leading independent owner of containerships with a diversified fleet of mid-sized and smaller containerships. Incorporated in the Marshall Islands, Global Ship Lease commenced operations in December 2007 with a business of owning and chartering out containerships under fixed-rate charters to top tier container liner companies. It was listed on the New York Stock Exchange in August 2008. Our fleet of 71 vessels as of December 31, 2024 had an...

Atea Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Written by Customer Service on May 12, 2025. Posted in Earnings Releases And Operating Results.

Enrollment Ongoing in Phase 3 C-BEYOND Trial for Treatment of HCV Full Phase 2 Results for Regimen of Bemnifosbuvir and Ruzasvir for HCV and Results from Three Additional Phase 1 Studies Supporting Potential Best-in-Class Profile Presented at European Association for the Study of the Liver (EASL) Congress 2025 Virtual Investor Event with Key Opinion Leader Insights on HCV to be Held May 14, 2025, at 10:00 AM ET BOSTON, May 12, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today reported financial results for the first quarter ended March 31, 2025 and provided a business update. The Company’s combination regimen of bemnifosbuvir (BEM), a nucleotide...

FutureFuel Releases First Quarter 2025 Results

Written by Customer Service on May 12, 2025. Posted in Earnings Releases And Operating Results.

Reports Net Loss of $17.6 Million or $0.40 per Diluted Share, and Adjusted EBITDA of ($16.1) Million CLAYTON, Mo., May 12, 2025 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the first quarter ended March 31, 2025. First quarter 2025 Financial Highlights (all comparisons are with the first quarter of 2024)Revenues were $17.5 million, a decrease of 70% or $40.7 million compared to $58.3 million. Net loss was $17.6 million, or $0.40 per diluted share, down from a net income of $4.3 million, or $0.10 per diluted share. Adjusted EBITDA(1) was ($16.1) million, down from $7.1 million.(1) A non-GAAP financial measure. See “Non-GAAP Financial Measures” for a description of the measure and a reconciliation to the...

Natural Gas Services Group, Inc. Reports First Quarter 2025 Financial and Operating Results; Increases 2025 Guidance

Written by Customer Service on May 12, 2025. Posted in Earnings Releases And Operating Results.

Midland, Texas, May 12, 2025 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced financial results for the three months ended March 31, 2025. The Company also raised the high-end of its full-year 2025 Adjusted EBITDA guidance to $79 million, citing continued strength in its business and growing demand across its fleet. First Quarter 2025 HighlightsRental revenue of $38.9 million for the first quarter of 2025 representing a 15% year-over-year increase and a 2% sequential increase compared to the period ended December 31, 2024.Net income of $4.9 million or $0.38 per diluted share for the first quarter of 2025 compared to net income of $5.1 million or $0.41 per diluted...

Getty Images Reports First Quarter 2025 Results

Written by Customer Service on May 12, 2025. Posted in Earnings Releases And Operating Results.

Q1 Revenue Growth of 0.8%, Currency Neutral Growth of 2.6% Q1 Annual Subscription Revenue Growth of 5.4%, Currency Neutral 7.2% Annual Subscription Revenue Rose to 57.2% of Total Revenue in Q1 Updates 2025 Guidance to Reflect FX Impacts, while Reaffirming Currency Neutral Revenue Growth OutlookNEW YORK, May 12, 2025 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the first quarter ended March 31, 2025. “Results in the first quarter were consistent with our expectations, with growth highlighted by gains across our subscription business, and continued customer value delivered through our offerings,” said Craig Peters, Chief Executive Officer for Getty Images. “We remain committed to investing...

Day: May 12, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals